STOCK TITAN

Philips to repurchase up to 6 million shares to cover long-term incentive plans

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Royal Philips (NYSE: PHG) has announced a share repurchase program to acquire up to 6 million shares, valued at approximately EUR 125 million at current prices. The buyback is specifically intended to cover obligations arising from the company's long-term incentive plans. The repurchases will be executed through forward transactions during Q2 and Q3 2025, complying with Market Abuse Regulation and shareholder authorization from May 8, 2025. The company expects to receive the shares in 2027.
Royal Philips (NYSE: PHG) ha annunciato un programma di riacquisto di azioni per acquisire fino a 6 milioni di titoli, per un valore di circa 125 milioni di euro ai prezzi attuali. Il riacquisto è destinato specificamente a coprire gli obblighi derivanti dai piani di incentivazione a lungo termine della società. Le operazioni di riacquisto saranno eseguite tramite transazioni a termine nel secondo e terzo trimestre del 2025, nel rispetto del Regolamento sul Market Abuse e dell'autorizzazione degli azionisti del 8 maggio 2025. La società prevede di ricevere le azioni nel 2027.
Royal Philips (NYSE: PHG) ha anunciado un programa de recompra de acciones para adquirir hasta 6 millones de títulos, valorados en aproximadamente 125 millones de euros a precios actuales. La recompra está destinada específicamente a cubrir las obligaciones derivadas de los planes de incentivos a largo plazo de la compañía. Las recompras se ejecutarán mediante transacciones a plazo durante el segundo y tercer trimestre de 2025, cumpliendo con el Reglamento sobre Abuso de Mercado y la autorización de los accionistas del 8 de mayo de 2025. La empresa espera recibir las acciones en 2027.
로열 필립스(NYSE: PHG)는 현재 가격 기준 약 1억 2,500만 유로 상당의 최대 600만 주를 매입하는 자사주 매입 프로그램을 발표했습니다. 이번 자사주 매입은 회사의 장기 인센티브 계획에서 발생하는 의무를 충당하기 위한 것입니다. 매입은 2025년 2분기와 3분기 동안 선도 거래를 통해 이루어지며, 시장남용규정과 2025년 5월 8일 주주 승인에 따라 진행됩니다. 회사는 2027년에 주식을 수령할 예정입니다.
Royal Philips (NYSE : PHG) a annoncé un programme de rachat d'actions visant à acquérir jusqu'à 6 millions d'actions, pour une valeur d'environ 125 millions d'euros aux prix actuels. Ce rachat est spécifiquement destiné à couvrir les obligations découlant des plans d'incitation à long terme de la société. Les rachats seront effectués par des transactions à terme au cours des deuxième et troisième trimestres 2025, conformément au Règlement sur les abus de marché et à l'autorisation des actionnaires du 8 mai 2025. La société prévoit de recevoir les actions en 2027.
Royal Philips (NYSE: PHG) hat ein Aktienrückkaufprogramm angekündigt, um bis zu 6 Millionen Aktien im Wert von etwa 125 Millionen Euro zu aktuellen Kursen zu erwerben. Der Rückkauf dient speziell dazu, Verpflichtungen aus den langfristigen Anreizplänen des Unternehmens zu erfüllen. Die Rückkäufe werden im 2. und 3. Quartal 2025 über Termingeschäfte durchgeführt und entsprechen der Marktmissbrauchsverordnung sowie der Aktionärsgenehmigung vom 8. Mai 2025. Das Unternehmen erwartet, die Aktien im Jahr 2027 zu erhalten.
Positive
  • Share repurchase program of up to 6 million shares demonstrates company's commitment to employee incentive plans
  • Forward transaction structure allows for efficient capital allocation and planned delivery in 2027
  • Program complies with regulatory requirements and shareholder authorization
Negative
  • Buyback limited to covering incentive plans rather than returning capital to shareholders
  • EUR 125 million capital allocation for employee compensation could impact other investment opportunities

June 4, 2025 

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today announced that it will repurchase up to 6 million shares to cover certain of its obligations arising from its long-term incentive plans. At the current share price, the shares represent an amount of up to approximately EUR 125 million.

The repurchases will be executed through one or more individual forward transactions, to be entered into in the course of the second and third quarter of 2025, in accordance with the Market Abuse Regulation and within the limits of the authorization granted by the company’s General Meeting of Shareholders on May 8, 2025. Philips expects to take delivery of the shares in 2027. Further details will be available via this link.

For further information, please contact:
Michael Fuchs
Philips Global External Relations
Tel.: +31 6 1486 9261
E-mail: michael.fuchs@philips.com

Dorin Danu
Philips Investor Relations
Tel.: +31 20 59 77055
E-mail: dorin.danu@philips.com

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Forward-looking statements
This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.



FAQ

What is the size of Philips' (PHG) 2025 share repurchase program?

Philips will repurchase up to 6 million shares, valued at approximately EUR 125 million at current share prices.

What is the purpose of Philips' (PHG) 2025 share buyback?

The share repurchase is specifically intended to cover obligations arising from the company's long-term incentive plans.

When will Philips (PHG) execute its 2025 share repurchase program?

The repurchases will be executed through forward transactions during the second and third quarters of 2025, with delivery expected in 2027.

Has Philips (PHG) received shareholder approval for the 2025 buyback?

Yes, the repurchase program was authorized by the company's General Meeting of Shareholders on May 8, 2025.

When will Philips (PHG) take delivery of the repurchased shares?

Philips expects to take delivery of the repurchased shares in 2027.
Koninklijke Phil

NYSE:PHG

PHG Rankings

PHG Latest News

PHG Stock Data

21.21B
925.01M
6.49%
0.26%
Medical Devices
Healthcare
Link
Netherlands
Amsterdam